Education and Training
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- diagnostic test: Menstrual Blood Analysis (Menstrual Blood Analysis)
Eligibility
Inclusion Criteria:
There will be two study groups: 1) menstruating women over the age of 18 who have previous
history of HR-HPV in the last 18 months and 2) menstruating women over the age of 18 who do
not have a previous history of HR-HPV.
Exclusion Criteria:
- Women younger than 18 years old or are not menstruating regularly
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Klaira M Lerma, MPH
16507211562
I'm interested